OBJECTIVE: To describe HIV incidence and HIV-associated mortality in a cohort of factory workers and their spouses with access to adequate sexually transmitted diseases (STD) treatment services and moderate exposure to sexual health interventions. METHODS: Follow-up visits at 4-month intervals and home follow-up of those who failed to keep appointments were used to estimate HIV incidence and mortality in a cohort of factory workers and their spouses in Mwanza, Tanzania, during 1991 to 1996. RESULTS: HIV prevalence at intake was 10.5% and 15.3% among 1,594 men and 880 women, respectively. HIV incidence was just over 1/100 person-years (PY) in 1,427 men and 1.9/100 PY in 745 women. The main risk factors were related to sexual behavior and clinical evidence of an STD, although only one seventh of those with HIV seroconversions had had an STD during the period following the second-from-last follow-up visit. HIV incidence among discordant couples was 5.0 and 8.3/100 PY for 41 men and 37 women, respectively. Mortality rates were 9.0 and 7.8/1,000 PY for men and women, respectively, and 65% of male and 60% of female deaths were attributable to HIV infection. CONCLUSIONS: In this factory population with good access to and use of STD treatment and with a moderate level of exposure to HIV prevention education, HIV incidence among men and women is still over 1/100 PY, which suggests a relatively high level of program effort is needed to lower incidence. More than half of all adult deaths were attributable to HIV, but greater increases in HIV-associated mortality are likely.
OBJECTIVE: To describe HIV incidence and HIV-associated mortality in a cohort of factory workers and their spouses with access to adequate sexually transmitted diseases (STD) treatment services and moderate exposure to sexual health interventions. METHODS: Follow-up visits at 4-month intervals and home follow-up of those who failed to keep appointments were used to estimate HIV incidence and mortality in a cohort of factory workers and their spouses in Mwanza, Tanzania, during 1991 to 1996. RESULTS: HIV prevalence at intake was 10.5% and 15.3% among 1,594 men and 880 women, respectively. HIV incidence was just over 1/100 person-years (PY) in 1,427 men and 1.9/100 PY in 745 women. The main risk factors were related to sexual behavior and clinical evidence of an STD, although only one seventh of those with HIV seroconversions had had an STD during the period following the second-from-last follow-up visit. HIV incidence among discordant couples was 5.0 and 8.3/100 PY for 41 men and 37 women, respectively. Mortality rates were 9.0 and 7.8/1,000 PY for men and women, respectively, and 65% of male and 60% of female deaths were attributable to HIV infection. CONCLUSIONS: In this factory population with good access to and use of STD treatment and with a moderate level of exposure to HIV prevention education, HIV incidence among men and women is still over 1/100 PY, which suggests a relatively high level of program effort is needed to lower incidence. More than half of all adult deaths were attributable to HIV, but greater increases in HIV-associated mortality are likely.
Authors: Joan H Skurnick; Paul Palumbo; Anthony DeVico; Barbara L Shacklett; Fred T Valentine; Michael Merges; Roberta Kamin-Lewis; Jiri Mestecky; Thomas Denny; George K Lewis; Joan Lloyd; Robert Praschunus; Amanda Baker; Douglas F Nixon; Sharon Stranford; Robert Gallo; Sten H Vermund; Donald B Louria Journal: J Infect Dis Date: 2002-01-17 Impact factor: 5.226
Authors: Robert Kairania; Ronald H Gray; Noah Kiwanuka; Fredrick Makumbi; Nelson K Sewankambo; David Serwadda; Fred Nalugoda; Godfrey Kigozi; John Semanda; Maria J Wawer Journal: AIDS Care Date: 2010-09
Authors: Ben Lopman; Constance Nyamukapa; Phyllis Mushati; Zivai Mupambireyi; Peter Mason; Geoff P Garnett; Simon Gregson Journal: Int J Epidemiol Date: 2008-01-18 Impact factor: 7.196
Authors: Francesca Lemme; Aoife M Doyle; John Changalucha; Aura Andreasen; Kathy Baisley; Kaballa Maganja; Deborah Watson-Jones; Saidi Kapiga; Richard J Hayes; David A Ross Journal: PLoS One Date: 2013-06-21 Impact factor: 3.240
Authors: Guy de Bruyn; Amalia Magaret; Jared M Baeten; Jairam R Lingappa; Patrick Ndase; Connie Celum; Anna Wald Journal: BMC Infect Dis Date: 2012-10-30 Impact factor: 3.090